🐂 DOW $1.1M Call Buy — Smart Money Front-Runs Q1 Earnings & Iran PE Supply Shock

📅 April 17, 2026 | 🔥 Unusual Options Activity Detected

🎯 The Quick Take

Someone just dropped $1.1 million on DOW calls at 10:05 AM this morning — 10,000 contracts of the $37.50 strike expiring May 15, 2026, with volume more than doubling open interest (10K vs. 4.5K OI). That's a fresh opening bet, not a hedge. With DOW's Q1 2026 earnings dropping next Thursday, April 23, and an Iran-war-driven polyethylene supply shock lifting polymer prices globally, this trade looks like an institutional player positioning for a cyclical earnings beat ahead of the consensus.

📊 Company Overview

Dow Inc. (NYSE: DOW) is the world's largest producer of polyethylene by nameplate capacity and one of the most integrated ethylene producers on the U.S. Gulf Coast:

Market Cap: ~$28.7 billion
Industry: Plastics Materials, Synthetic Resins & Non-Vulcan Elastomers (SIC 2821)
Current Price (April 17, 2026): ~$34.86–$35.44 intraday range
52-Week Range: $20.40 – $42.74
Primary Business: Polyethylene, polyurethanes, silicones, coatings, and specialty chemicals across Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings segments

DOW is a deep-cyclical chemicals name emerging from a multi-year downcycle. After reporting a full-year GAAP net loss of $2.4B in 2025 and cutting its dividend 50% in July 2025, the company launched an aggressive transformation plan in January 2026 and is now benefiting from an unexpected supply-side windfall from the Iran-war disruption to global petrochemical flows.

💰 The Option Flow Breakdown

The Tape (April 17, 2026 @ 10:05:53 AM ET):

Time	Symbol	Side	Buy/Sell	Type	Expiration	Premium	Strike	Volume	OI	Spot	Option Price
10:05:53	DOW	BUY	BUY	DOW20260515C37.5	2026-05-15	$1.1M	$37.50	10K	4.5K	$34.86	$1.10

🤓 What This Actually Means

This is a directional opening bet, not a hedge. Here's the anatomy:

💸 Premium paid: $1.1M ($1.10 per contract × 10,000 contracts × 100 shares)
🎯 Strike context: $37.50 sits 7.6% out-of-the-money vs. the $34.86 spot — meaningful upside conviction required
⏰ Strategic timing: 28 days to expiration, capturing next Thursday's Q1 2026 earnings (April 23) and the full May OPEX cycle
📊 Volume vs. OI: 10,000 contracts traded vs. only 4,500 open interest — this almost certainly represents new opening buying (Vol/OI ratio of 2.2x, classified HIGH_ACTIVITY)
🏦 Institutional fingerprint: $1.1M in a single sweep at 10:05 AM is not retail Robinhood behavior

What's really happening here: This trader is front-running the April 23 earnings event with a leveraged bullish position. At $1.10 per contract, they're risking a defined $1.1M for a shot at significant upside if DOW's Q1 results show the Iran-war PE price hikes flowing through revenue — or if management delivers a strong Transform to Outperform update that causes analysts to reset targets sharply higher.

The $37.50 strike is not random. As you'll see in the gamma analysis below, $37.50 is a major call gamma concentration level — the options market already has heavy interest there, and breaking through it could trigger dealer covering activity that amplifies the move.

Unusual Score: Vol/OI ratio of 2.22x with 10,000 contracts in a single print — this is roughly a few-times-a-month event in DOW options and well above the norm for a name that trades maybe 2,000–4,000 total contracts on a quiet day.

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

YTD Performance

DOW has staged one of the more dramatic cyclical recoveries in the S&P 500 Materials sector in 2026. After bottoming near the $20.40 52-week low in mid-2025 (the dividend cut low), the stock has nearly doubled off those levels, trading in the mid-$30s as of April 17.

Key observations:

📈 Cyclical rebound underway: Materials has been the strongest S&P 500 sector since late February 2026, per 24/7 Wall St., and DOW has led that move
🔵 Dividend cut is in the rearview: The July 2025 50% cut from $0.70 to $0.35 per share (Yahoo Finance) removed the overhang that had been crushing the stock — now it's priced in
🟠 Analyst target reset in progress: Wells Fargo raised to $48 (March 30), Citi upgraded to Buy with a $40 target (March 12) per Benzinga — those are still above current price of ~$35
⚠️ Still below the 52-week high of $42.74: There's significant room between current price and where analysts now see fair value, which is the bull case argument

Gamma-Based Support & Resistance Analysis

DOW Gamma S/R

Current Price: ~$35.44

The gamma exposure map shows where options market makers have the largest hedging obligations, creating natural price magnets and barriers:

🔵 Support Levels (Put Gamma Below Price):

$35.00 — Strongest nearby floor with 24.8B total gamma exposure (18.2B call GEX + 6.6B put GEX, net bullish 11.6B). This is the LINE IN THE SAND just below current price. Dealers will be buyers of stock as price approaches this level.
$32.50 — Secondary support at 5.7B total gamma; net put-dominated at this level (negative 0.3B net GEX) — means less mechanical buying support here, more a natural open interest cluster
$30.00 — Deep structural floor at 5.75B gamma; negative net GEX signals dealer hedging creates natural buying on drops to this level

🟠 Resistance Levels (Call Gamma Above Price):

$36.00 — Immediate ceiling at 3.0B total gamma; notably PUT-dominated (–2.7B net GEX) meaning dealers are short calls AND long puts here — this creates real selling pressure on rallies through $36
$37.00 — Secondary resistance at 4.7B gamma (also put-dominated, –1.7B net GEX). Stack of resistance before the trade's strike.
$37.50 — THIS IS WHERE THE TRADE IS STRUCK. 10.7B total gamma (8.6B call GEX + 2.1B put GEX, net bullish +6.5B) — the STRONGEST call gamma level in the resistance stack. If price can push through here, dealers are forced to buy stock aggressively to delta-hedge their short calls. This is a classic gamma squeeze setup.
$38.00 — Heavy resistance at 6.75B gamma (strongly put-dominated, –6.5B net GEX); this is a real ceiling above the trade's strike
$40.00 — Extended resistance at 6.5B gamma (net call-positive +3.1B); key round number target for the bull case
$42.50 — Upper resistance at 4.9B gamma (net call-positive +4.2B); near the 52-week high of $42.74

What this means for traders: DOW needs to climb from ~$35.44 through three layers of resistance ($36, $37, $37.50) for this call to reach its strike. But the $37.50 level itself — with the highest call gamma of any resistance level — actually becomes FAVORABLE once price clears it, because dealers scramble to buy stock to hedge. The call buyer appears to know this structure.

Net GEX Bias: Bullish (54.5B call GEX vs. 38.8B put GEX) — overall positioning skews bullish, supporting the directional bet, even though there's resistance to navigate in the near term.

Implied Move Analysis

DOW Implied Move

Options market pricing for upcoming expirations:

📅 Weekly (April 24 — 7 days): ±$2.44 (±6.9%) → Range: $32.98 – $37.86. This captures Q1 2026 earnings on April 23 — the market expects a BIG earnings move. Upper range of $37.86 nearly touches the $37.50 strike!
📅 Monthly OPEX (May 15 — 28 days — THIS TRADE!): ±$3.46 (±9.77%) → Range: $31.96 – $38.88. The upper range at $38.88 sits comfortably above the $37.50 strike — meaning the options market implies the strike IS reachable by May 15 within one standard deviation.
📅 LEAPS (March 19, 2027 — 336 days): ±$10.60 (±29.9%) → Range: $24.82 – $46.02

Key insight: The May 15 implied move upper range of $38.88 means the call buyer needs roughly a +8% move from current levels to land in-the-money — and the market is already pricing nearly a ±10% swing for that window. This isn't a lottery ticket; it's within the implied probability range. If earnings catalyze even a moderate beat, this trade is in play.

The weekly implied move of ±6.9% around earnings tells you the options market is already pricing in major volatility for April 23. That's the event this call position is built around.

🎪 Catalysts

🔥 Immediate Catalyst: Q1 2026 Earnings — April 23, 2026 (6 DAYS AWAY!)

Per Dow's investor relations events page and MarketBeat earnings data:

Pre-market, 8:00 AM ET — report drops before the open
Consensus Revenue: $9.45B (down ~9.5% YoY) per Investing.com
Consensus EPS: –$0.31 to –$0.33 loss (narrower than Q4 2025's –$0.34 beat) per Nasdaq earnings tracker and Zacks

What to watch:

🟠 Polyethylene average selling price lift from the Iran-war supply disruption — this is the #1 bull catalyst
🟠 Transform to Outperform $500M 2026 savings pacing and Q1 in-quarter realization
🔵 Dividend reaffirmation at $0.35 (expected but critical — another cut would be sharply negative)
🔵 Volume response to March/April 2026 price hike announcements

The Q4 2025 earnings (January 29) showed DOW beat the EPS consensus by $0.17 (–$0.34 actual vs. –$0.51 consensus) on essentially flat revenue — a pattern that could repeat if Iran-war pricing flows through faster than the models expect.

🚀 Near-Term Catalyst: Iran War / Strait of Hormuz PE Supply Shock

This is the structural story beneath the trade. Per CEO Jim Fitterling's comments to Fortune and Benzinga:

~20% of global petrochemical capacity is blocked by the Strait of Hormuz closure
Up to 50% of polyethylene supply is offline, constrained, or impacted post-conflict (Hydrocarbon Processing)
250–275 day recovery window even once the strait reopens — "the die is being cast" for elevated prices through end of 2026
Asia naphtha refining margin jumped from ~$108/ton to over $400/ton over Brent per CNBC's Iran war coverage
Dow announced polyethylene and ethyleneamines price hikes in both March and April 2026 per Green Chem Industries and GuruFocus

Why this matters for the call buyer: Dow has structural ethane cost advantage over naphtha-based competitors in Europe and Asia. When global PE prices surge due to Middle East supply disruption, U.S. Gulf Coast producers like DOW benefit on both the price and the margin side simultaneously. This is a genuine $1B+ annualized EBITDA swing factor at scale.

🏗️ Near-Term: Transform to Outperform — $2B EBITDA Plan

Per Dow's January 29 press release and Manufacturing Dive's deep dive:

$500M in-year 2026 savings target from a $2B total EBITDA uplift program
~4,500 role reductions (13% of workforce), with AI and automation as enablers per Houston Public Media
+$1.2B incremental in 2027, +$300M in 2028 — this is a multi-year earnings ramp story
Q1 2026 will be the first quarter where management must show concrete savings progress — a beat here could meaningfully reset estimates

👩‍💼 CEO Transition — Karen Carter Takes Over July 1, 2026

Per Dow's succession press release and Fortune's coverage:

Karen S. Carter (current COO, 30+ years at Dow) becomes CEO on July 1, 2026 — Dow's first female CEO in 126 years
Jim Fitterling moves to Executive Chair, focusing on long-term strategy
Fortune characterizes this as a continuity-positive multi-year plan — no abrupt strategic pivot expected

The call's May 15 expiration sits neatly ahead of the CEO transition, capturing the Q1 earnings binary event without the additional uncertainty of a new management regime.

✅ Past Catalyst Now Resolved: Dividend Cut (July 2025)

Per Yahoo Finance and Dow's investor relations page:

Quarterly dividend cut from $0.70 to $0.35 per share in July 2025 — the largest single overhang on the stock removed
Confirmed at $0.35 for the March 13, 2026 payment per Koyfin dividend tracker — the reduced level is sticky
~$1B+ annual cash savings retained for balance sheet — structural improvement, not a one-time event
Any further cut would be sharply negative; a reaffirmation next Thursday is the base case

🎲 Price Targets & Probabilities

Using gamma levels, implied move data, earnings timing, and the Iran-war catalyst backdrop:

📈 Bull Case (30% probability)

Target: $38–$40

How we get there:

💪 Q1 2026 earnings beat consensus significantly — PE price hikes from Iran-war disruption flow through faster than models expect, driving revenue toward $9.7B+ and EPS loss narrowing to –$0.15 or better
🟠 Transform to Outperform Q1 savings pacing demonstrates $100M+ in-quarter realization, giving credibility to the $500M 2026 full-year target
💰 Dividend reaffirmed at $0.35 with language suggesting sustainable trajectory
📈 Analyst target upgrades follow earnings — Mizuho (currently $39) and UBS (currently $37) both raise targets, pulling consensus toward Wells Fargo's $48 and Citi's $40
🔵 Break above $36 resistance triggers gamma-driven momentum; clearing $37.50 where 10.7B call GEX is concentrated could cause dealer short-covering to amplify the move toward $38–$40
The May 15 implied move upper range of $38.88 supports this scenario as within one standard deviation

This trade's P&L in Bull Case:

Stock at $38 on May 15: Calls worth ~$0.60–$0.80 (intrinsic $0.50 + remaining time value) — partial winner
Stock at $40 on May 15: Calls worth ~$2.50 — $1.4M gain (127% ROI on $1.1M invested)
Stock at $38.88 (implied move upper): Calls worth ~$1.40 — ~$300K gain (27% ROI)

Why 30%: DOW is still consensus-loss and the stock needs a meaningful positive surprise to move 7.6% through the strike. Possible, but requires the Iran-war tailwind to show up meaningfully in Q1 numbers — and Q1 is just the first quarter where those March/April price hikes begin flowing through.

🎯 Base Case (50% probability)

Target: $33–$37 range (consolidation around current levels)

Most likely scenario:

✅ Earnings roughly in line: revenue $9.3–9.5B, EPS –$0.25 to –$0.35, no major negative surprises
📊 Transform to Outperform update is encouraging but not spectacular — management sticks to the $500M 2026 guide
🔵 Dividend reaffirmed at $0.35 — market views this as stabilizing, no re-rating catalyst
⚖️ Iran-war PE pricing acknowledged as tailwind but won't fully show up until Q2/Q3 2026 — patience required
📉 Stock trades between $35 support (24.8B gamma floor at $35) and $37 resistance ceiling (4.7B gamma), oscillating within the gamma range
💤 Implied volatility crush after earnings drops the $1.10 calls to $0.20–$0.40 — this is the most common outcome for OTM earnings calls

This is the call buyer's risk scenario: Stock goes sideways or slightly up, but doesn't breach the $37.50 strike, and the $1.1M premium decays to near zero. The bet was simply wrong on timing.

Why 50%: DOW's consensus still calls for a loss quarter. The Iran-war pricing is real, but a 7.6% OTM call expiring in 28 days requires a significant upside surprise plus immediate price action — that's a demanding combination.

📉 Bear Case (20% probability)

Target: $30–$33

What could go wrong:

😰 Q1 2026 earnings miss — revenue falls below $9B due to volume weakness from tariff-driven demand disruption; loss wider than –$0.33 consensus
🚨 Dividend guidance softened or another cut signaled — stock could gap down 10–15% on any dividend language that suggests risk
⚠️ Transform to Outperform savings delayed — restructuring charges hit GAAP hard with no offsetting benefit yet
🇨🇳 Tariff escalation crimps polyurethane and coatings demand in the key construction and automotive end markets
📊 Macro: recession fears intensify, materials sector rotates out sharply
🔨 Break below $35 gamma support (24.8B) removes the mechanical floor; next meaningful gamma support is $32.50 and $30

Critical support levels to watch:

🛡️ $35.00: Strongest gamma floor (24.8B total GEX, net bullish +11.6B) — losing this level is the bearish signal
🛡️ $32.50: Secondary support at 5.7B gamma
🛡️ $30.00: Deep floor at 5.75B gamma; below this is territory not seen since the 52-week low of $20.40

Call P&L in Bear Case:

Stock at $33 on May 15: Calls expire worthless — full $1.1M loss (100%)
Stock at $30 on May 15: Calls expire worthless — full $1.1M loss (100%)
Both bear scenarios result in total premium loss; that's the defined risk of buying OTM calls

Why 20%: DOW beat Q4 consensus by $0.17; the Iran-war supply shock is a genuine structural tailwind for a U.S. ethane-advantaged producer. The probability of a severe miss is lower than the bullish/flat outcomes given the macro tailwinds, but macro and tariff risk is real and non-trivial.

💡 Trading Ideas

🛡️ Conservative: Wait for Post-Earnings Clarity

Play: Stay sidelined until after April 23 earnings, then reassess

Why this works:

⏰ Q1 2026 earnings in 6 days create a binary event — the stock can gap 7–10% either direction based on the Iran-war PE pricing update and dividend language
💸 Implied volatility is elevated heading into earnings — options premiums are expensive right now; buying after IV crush means cheaper access to the same thesis
📊 If DOW delivers a solid earnings beat and the stock moves to $37–$38, you can buy post-earnings calls or stock at a better risk/reward without paying for the event risk
🎯 Target entry: If stock holds $35 gamma support post-earnings and closes above $36, that's your confirmation signal
👀 Watch specifically for: dividend reaffirmation, Transform to Outperform Q1 savings figure, and any PE price hike volume commentary

Action plan:

Hold cash through April 23
Set alert at $36.50 post-earnings for potential entry on a stock position
If stock gaps down 5%+ on bad news, reassess the thesis entirely — don't catch falling knives

Risk level: Minimal (cash position) | Skill level: Beginner-friendly

⚖️ Balanced: Bull Call Spread (Defined Risk)

Play: Buy a $36/$39 call spread expiring May 15, 2026

Structure: Buy the $36 call, sell the $39 call (same May 15 expiration as this institutional trade)

Why this works:

📊 Reduces cost vs. buying the $37.50 calls outright — selling the $39 upside helps fund the trade
🎯 The $36/$39 spread captures the move from $36 (immediate resistance) through $39 (near the implied move upper), which is the most realistic bull scenario
🛡️ Defined risk — maximum loss is the net debit paid, no more
⚖️ The $39 level is near the May 15 implied move upper ($38.88), making it a reasonable ceiling to sell
💰 If this is entered pre-earnings, expect the spread to cost approximately $0.80–$1.20 net debit

Estimated P&L (pre-earnings entry):

Cost: ~$0.90–$1.10 per spread (depends on IV)
Max profit: ~$1.90–$2.10 at $39+ on May 15 (~180% ROI)
Max loss: ~$0.90–$1.10 (defined, if stock below $36 at expiry)
Breakeven: ~$37.00–$37.10

Timing note: Enter before April 23 earnings if you have conviction on the beat, OR wait until after the report and re-price — post-earnings IV crush will make this spread cheaper if the stock doesn't already move decisively.

Position sizing: No more than 2–3% of portfolio on a pre-earnings options spread.

Risk level: Moderate (defined risk, directional) | Skill level: Intermediate

🚀 Aggressive: Replicate the Institutional Trade (ADVANCED ONLY)

Play: Buy the $37.50 calls expiring May 15, 2026 — same as the institutional trade

Why this could work:

🐂 If the Iran-war PE pricing flows through Q1 revenue and management delivers a bullish Transform to Outperform update, DOW could spike 10–12% on earnings day alone
🎰 The weekly implied move of ±6.9% means the stock COULD touch $37.50 on the earnings move alone — the strike is within one weekly implied move from current price
🔥 The $37.50 level has 10.7B call gamma stacked on it — if the stock approaches it, gamma squeeze mechanics could amplify the move as dealers hedge
📊 Wells Fargo has a $48 price target; Citi upgraded to $40 — institutional consensus is moving toward DOW being meaningfully undervalued if earnings inflect

Why this could blow up (SERIOUS RISKS):

💸 Full premium loss risk: At $1.10 per contract, if DOW is below $37.50 on May 15, you lose 100% — no partial recovery
📉 IV crush is brutal: Even if DOW goes up 5% on earnings, the IV collapse post-event may keep the $37.50 calls deeply OTM and nearly worthless
⏰ Theta kills OTM calls fast: With 28 DTE and 7.6% OTM, theta decay accelerates significantly in the final 2 weeks — if the move doesn't happen quickly, time works against you
⚠️ Consensus is still a loss: Buying OTM calls pre-earnings on a name where consensus expects negative EPS is a high-conviction speculative bet, not a high-probability trade

Estimated P&L:

Buy at ~$1.10; cost per contract = $110
Stock at $37.50 on May 15 (at-the-money): worth $0 (time value gone) — lose ~90%
Stock at $39 on May 15: worth ~$1.50 — small gain of ~$0.40 per contract
Stock at $40 on May 15: worth ~$2.50 — gain of ~$1.40 per contract (127% ROI)
Stock at $35 or below at expiry: worth $0 — full loss

CRITICAL WARNING: Only consider this trade if you:

✅ Understand that OTM pre-earnings calls have a high probability of full premium loss
✅ Size it at 0.5–1% of portfolio maximum
✅ Have a plan to sell or roll within 24–48 hours post-earnings regardless of outcome
✅ Accept that even being right on direction may not save you if IV crush is severe
✅ Are not relying on this trade — treat it as a lottery ticket with thesis backing, not a core position

Risk level: HIGH (100% premium loss is the most common outcome for OTM earnings calls) | Skill level: Advanced only

⚠️ Risk Factors

Don't get caught by these potential landmines:

⏰ Earnings binary event in 6 days: Q1 2026 results pre-market April 23 create a gap risk of 7–10% either direction. The stock needs a meaningful positive surprise to move the $37.50 calls into the money. Historical context: DOW beat Q4 2025 EPS consensus by $0.17, but revenue slightly missed. A similar pattern could produce a muted stock reaction — not enough to reach $37.50.
💸 OTM with 7.6% gap required: The $37.50 strike is 7.6% above the $34.86 entry spot. For a cyclical chemicals stock, that's a meaningful hurdle in 28 days. The May 15 implied move upper range of $38.88 indicates the market prices it as reachable — but reachable within the implied range means roughly a 16% probability based on options pricing alone.
📉 IV crush post-earnings: Whatever the earnings outcome, implied volatility will collapse sharply after the April 23 report. If DOW rises 4–5% but stays below $37.50, the OTM calls could still lose 60–80% of their value on IV crush alone. This is the most overlooked risk for pre-earnings call buyers.
🇺🇸 Tariff risk and securities litigation: U.S. tariffs have pushed Dow to a "lower-for-longer" outlook per ICIS CEO commentary. A tariff-related securities class action with an amended complaint filed March 31, 2026 per D&O Diary could resurface as a headline risk. Chemicals distribution is particularly exposed to tariff-driven demand softness — the ChemCeed estimate is $18B in added industry costs.
🏭 2H 2026 capacity wave will cap pricing upside: The Iran-war supply shock is powerful but time-limited. Per Argus Media, ~2M t/yr of new U.S. PE capacity and ~4M t/yr of Asia additions are coming in 2H 2026 — once the Strait of Hormuz normalizes (Fitterling flagged a 250–275 day window), the pricing cycle could turn against DOW. The May 15 expiration safely precedes this risk, but it caps the medium-term story.
💰 Dividend tail risk: Any language in the April 23 earnings call suggesting the $0.35 quarterly dividend is under review again would be sharply negative. DOW already trades with a 3.6% yield at $35; income-oriented holders would exit aggressively. The Q2 2025 dividend cut caused a catastrophic gap — a repeat would be devastating.
📊 Transform to Outperform delivery risk: The $500M 2026 savings target requires 4,500 role reductions and restructuring charges of $1.1–1.5B per Manufacturing Dive. Q1 2026 is the first real checkpoint — if management can't show meaningful in-quarter savings realization, the multi-year EBITDA ramp thesis loses credibility.
🔵 Gamma resistance stack between $36–$37.50: The stock faces three layers of resistance ($36, $37, $37.50) with total gamma exposure before the strike. Even with a good earnings beat, mechanical dealer selling into this stack could slow or stall a rally short of the $37.50 strike within the 28-day window.
🐻 Macro recession risk: A 2H 2026 global recession remains the "elephant in the room" per AInvest's DOW outlook. DOW's volumes are highly cyclical — polyethylene demand is directly tied to consumer goods production, construction, and automotive. A growth stall would compress volumes faster than the Iran-war price hike can compensate.

🎯 The Bottom Line

Real talk: Someone just committed $1.1 million to a DOW call that needs the stock to rally 7.6% in 28 days, with Q1 2026 earnings on April 23 as the obvious catalyst. This is a focused, event-driven directional bet — not a hedge, not a complex structure. The thesis is straightforward: Iran-war PE supply shock + Transform to Outperform savings = Q1 earnings beat that re-rates the stock toward the $38–$40 range that Wells Fargo and Citi now see as fair value.

What this trade tells us:

🎯 The buyer believes Q1 2026 earnings will materially beat the –$0.31 to –$0.33 EPS consensus — likely because the March/April PE price hikes from the Strait of Hormuz disruption are showing up in Q1 revenue faster than sell-side models assume
💰 They're comfortable with 100% premium loss risk (that's the math on OTM options) — suggesting they've sized this as a speculative earnings trade, not a portfolio hedge
⚖️ The $37.50 strike choice is deliberate: it sits at the highest call gamma concentration above price, meaning a move through it triggers mechanical dealer buying that amplifies the squeeze
⏰ The May 15 expiration — not April 24 weekly — suggests they're buying buffer beyond earnings in case the move takes a few days to develop post-report

If you own DOW:

✅ Hold through earnings — the fundamental setup (Iran-war pricing + Transform to Outperform) is the best it's been in the current cycle
📊 Set a mental line at $35 gamma support — if that cracks on bad earnings news, reassess the position
🎯 Take partial profits near $38–$40 if earnings surprise to the upside — that's where the first meaningful resistance cluster sits ($38 at 6.75B gamma)
⚠️ Watch dividend language very carefully — any wavering on the $0.35 quarterly level is your exit signal, fast

If you're watching from the sidelines:

⏰ April 23, pre-market, 8:00 AM ET is the moment of truth — do not enter options positions right before earnings if you're not comfortable with binary gap risk
🎯 Post-earnings pullback to $33–$35 on a "good but not great" report would be an excellent entry for a stock position, targeting the $38–$40 analyst consensus range over 3–6 months
📊 Watch for: PE price hike volume acceptance, Transform to Outperform Q1 savings figure, any dividend commentary, and Path2Zero Alberta timeline updates

If you're bearish:

🎯 The fundamental bear case requires either a dividend re-cut, a significant earnings miss, or a macro shock — none of which is the base case right now
📊 First gamma support to watch: $35.00 (24.8B gamma wall) — breaking this with conviction would be the signal for a short-term bearish position toward $32.50–$30.00
⏰ Initiating bearish bets heading into a supply-shock earnings setup with analyst upgrades in progress is fighting the tape — wait for confirmation

Mark your calendar — Key dates:

📅 April 23, 2026 (Thursday) — Pre-market, 8:00 AM ET: Q1 2026 Earnings (6 DAYS AWAY — the primary catalyst for this trade)
📅 April 24, 2026: Weekly OPEX — ±6.9% implied move expires
📅 May 15, 2026: Monthly OPEX — expiration of this $1.1M call position; ±9.77% implied move ($31.96 – $38.88 range)
📅 Mid-2026: Barry, UK siloxanes plant shutdown completes per Dow IR
📅 July 1, 2026: Karen Carter assumes CEO role per Dow IR
📅 Late July 2026: Q2 2026 Earnings — next major earnings catalyst
📅 2H 2026: ~2M t/yr U.S. PE capacity additions begin — potential pricing headwind per Argus Media
📅 End of 2026: Iran war PE supply disruption still expected to be active per CEO Fitterling's Fortune interview

Final verdict: The DOW $37.50 May call trade is a well-constructed earnings bet with legitimate fundamental backing — the Iran-war PE supply shock is real, the Transform to Outperform savings are starting to flow, and analyst targets are moving sharply higher. The call buyer has a clear, defensible thesis. BUT — this is a 7.6% OTM call with 28 DTE on a name still expected to report a quarterly loss. The probability of full premium loss is the base case for this specific contract. The institutional buyer likely has the capital to absorb a $1.1M loss if wrong; retail traders should think carefully about sizing before following this flow.

Be patient. Let earnings clear April 23. The Iran-war story and the cyclical recovery don't disappear overnight — but there will be better risk/reward entry points after the binary event resolves.

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Past unusual options activity does not guarantee future price movements or profitability. Out-of-the-money options frequently expire worthless — full premium loss is a common outcome. Earnings events create binary gap risk that can result in significant losses for options holders regardless of direction. Always conduct your own research and consider consulting a licensed financial advisor before trading. Position sizing should reflect your personal risk tolerance and financial situation.

About Dow Inc.: Dow Inc. is a global materials science company with approximately 35,900 employees across 31 countries. The company operates across three business segments — Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings — serving customers in high-growth markets such as packaging, infrastructure, and consumer care. Dow is the world's largest producer of polyethylene by nameplate capacity, with a market cap of approximately $28.7 billion.

DOW Unusual Options Activity — 2026-04-17

Institutional flow on 2026-04-17

Trade Details

Full Analysis